Tirzepatide
GLP-1/GIP dual agonist · 10mg
99%+ Pure$120
Product Description
Tirzepatide is a dual GLP-1/GIP receptor agonist research peptide currently under investigation for various metabolic applications. As a dual agonist, it activates two distinct receptor pathways simultaneously, making it valuable for researchers studying complex metabolic processes and multi-target mechanisms. The compound has become increasingly popular in the research community for its unique dual-action profile.
Expert Insight
“Dual agonists have revolutionized metabolic research by allowing simultaneous investigation of two complementary pathways. Tirzepatide's GLP-1/GIP mechanism provides researchers with a powerful tool for understanding synergistic receptor activation and metabolic homeostasis.”
Research Pairing Suggestions
Researchers studying comprehensive metabolic optimization commonly pair these because Tirzepatide's dual-agonist effects on glucose metabolism complement 5-Amino-1MQ's NAD+-boosted metabolic enhancement.
Research Highlights
Dual GLP-1/GIP receptor agonism
Synergistic pathway activation for metabolic studies
Extensively documented in peer-reviewed research
This calculator is a math tool only. It does not provide medical advice. Vital Peptides Labs sells research peptides for laboratory and research use only. Users are strongly encouraged to read the linked research, consult qualified professionals, and draw their own conclusions before making any decisions.
Reconstitution Calculator— Tirzepatide
Research Literature — Tirzepatide
The following is a summary of published research literature. This information is provided for educational reference only and does not constitute medical advice or research amount guidance.
Research Amounts in Literature
In published clinical trials (SURPASS program), researchers administered Tirzepatide at 2.5 mg, 5 mg, 10 mg, and 15 mg per week. Protocols typically begin at 2.5 mg with 4-week escalation steps.
Frequency Protocols in Research
Published literature on Tirzepatide reports once-weekly subcutaneous administration protocols across all major clinical trials.
Reconstitution Concentrations in Research
Published literature reports reconstitution of 10 mg lyophilized vials in 2 mL bacteriostatic water, yielding a concentration of 5 mg/mL. This is the standard reconstitution volume referenced across major tirzepatide research protocols.
Typical Syringe Ranges in Research
At 5 mg/mL, weekly doses of 2.5–15 mg correspond to 50–300 units (0.5–3.0 mL) on a standard research syringe. Lower doses (2.5–5 mg) fit comfortably in a 1 mL syringe.
Published Sources
Tirzepatide
Add to your order
Pairs Well With
You'll Also Need
3mL / 23G Reconstitution Syringe
For mixing bacteriostatic water into lyophilized peptide vials
~$10–15
Buy on Amazon31G Research Syringe
For precise subcutaneous administration in research protocols
~$12–18
Buy on AmazonAlcohol Prep Pads
For sterilizing vial stoppers and work surfaces
~$5–8
Buy on AmazonBacteriostatic Water (10mL)
Sterile water with 0.9% benzyl alcohol for reconstitution
$10
ViewThis product is intended strictly for laboratory research and development purposes only. Not for human consumption, medical, veterinary, or household use. By purchasing this product, you confirm that you are at least 21 years of age and that the product will be used solely for legitimate research purposes.